17-hydroxysteroid Dehydrogenase Type 5 Gene Polymorphism (71A/G HSD17B5 SNP) and Effects of Oral Contraceptive Pill on Hirsutism, Androgens and Metabolic Profile in Non-obese PCOS Women: a Pilot Study
N/A
15 Years
40 Years
15 Years
40 Years
Not Enrolling
Female
Polycystic Ovary Syndrome
Female
Polycystic Ovary Syndrome
Trial Information
17-hydroxysteroid Dehydrogenase Type 5 Gene Polymorphism (71A/G HSD17B5 SNP) and Effects of Oral Contraceptive Pill on Hirsutism, Androgens and Metabolic Profile in Non-obese PCOS Women: a Pilot Study
Inclusion Criteria:
- hirsute women with polycystic ovary syndrome
Exclusion Criteria:
- Use of any drugs known to interfere with hormone levels for at least 3 months before
the study
- Women with type 2 diabetes, homa index > 3.8, liver or renal disease or thyroid
dysfunction
- Other hyperandrogenic disorders than PCOS
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Changes at Ferriman- Gallwey score
Outcome Time Frame:
6 months
Safety Issue:
No
Authority:
Brazil: National Committee of Ethics in Research
Study ID:
04-245
NCT ID:
NCT01372293
Start Date:
January 2005
Completion Date:
December 2010
Related Keywords:
- Polycystic Ovary Syndrome
- PCOS
- oral contraceptive pill
- polymorphisms
- Polycystic Ovary Syndrome
Name | Location |
|---|
